» Lipum on financial statements and BIO-Europe
» Alligator's CMO hosts in-depth webinar on Mitazalimab
» Carbiotix CEO on GRAS and the new production process
» BiBBInstruments wants to revolutionize the diagnostics of pancreatic cancer
» WntResearch's CEO on the option program and the NeoFox study
Read BioStock's newsletter for v.12 here.
Watch the latest episode of The IPO round in the banner below:
Morning news
BrainCool delivers RhinoChill System to Karolinska Institutet for a study in ultra-early cooling in patients with cardiac arrest. Read more.
SynAct Pharma will hold Capital Markets Day in Stockholm on May 5, 2023. Read more.
AlzeCure presents new data on its preventive treatment Alzstatin at the Alzheimer's conference AD/PD 2023. Read more.
Phase Holographic Imaging clarify potential collaboration partners. Read more.
Mendus announces request from Negma Group for conversion of convertible debentures. Read more.
By having signs Letter of Intent with Norwegian clinic for clinical study. Read more.
NextCells Clinical phase I/II study in type I diabetes accepted for publication in Diabetology. Read more.
EXACT Therapeutics presents encouraging clinical data from a case report at Science & Technology Event. Read more.
PharmaLundensis announces that the company's new issue was subscribed for approximately SEK 3,2 million. Read more.
Dicot has conducted the last meeting with Läkemedelsverket before applying for a clinical trial application. Read more.
Oncopeptides receives research grants from Vinnova to explore the PDC platform in solid tumors. Read more.
Biovica signs commercial partnership agreement for DiviTum TKa for the Netherlands and Poland. Read more.
Brain+ highlights Germany's new digitalization strategy. Read more.
Bioactive Bone Substitutes updates on the CE marking process. Read more.
Lipigon receives additional subscription commitment and top guarantee for rights issue. Read more.
BergenBio will present at upcoming scientific conferences. Read more.
Ambi announces registration of increased shareholding. Read more.
Martine van Vugt appointed as Genmabs Chief Strategy Officer. Read more.
On March 16th, we broadcast the first digital event of the year – BioStock Investor Meeting – with representatives from a number of life science companies. Watch the event again here via the banner below.
Annual reports:
BioGaia Herantis Pharma MedCap Olink Scandion Oncology
Summons:
AcouBlack
Share buyback program:
Genmab Novo Nordisk
News since monthlunch
DexTech Medical has informed about the myeloma study with OsteoDex. Read more.
FSA begins investigation of Klaria Pharma handling and disclosure of inside information. Read more.
WntResearchs vd Pernilla Sandwall presents the company on Swiss Nordic Bio March 30th. Read more.
BrainCool has received final approval for listing on Nasdaq First North Growth Market. Read more.
Diamyd Medical has announced that results from Remygenestudy will be presented in April. Read more.
MOT South revokes Getinge's CE certificate for Cardiosave. Read more.
Faro Capital has flagged down in EQL Pharma. Read more.
This morning's price development
Winner: PharmaLundensis 35,2%, Amniotics 18,1%, Scandinavian Real Heart 11,6%, Scibase Holding 10,6%, Hemcheck Sweden 10,1%
Förlorare: Klaria Pharma -14,9%, Lipigon Pharmaceuticals -14,6%, Phase Holographic -14,3%, Raytelligence -14,2%, Saniona -8,7%
Index: OMXS30 2116 0,22%, Healthcare -0,27%